A novel 913-amino acid protein, ␥-aminobutyric acid type A (GABA A ) receptor interacting factor-1 (GRIF-1), has been cloned and identified as a GABA A receptorassociated protein by virtue of its specific interaction with the GABA A receptor ␤2 subunit intracellular loop in a yeast two-hybrid assay. GRIF-1 has no homology with proteins of known function, but it is the rat orthologue of the human ALS2CR3/KIAA0549 gene. GRIF-1 is expressed as two alternative splice forms, GRIF-1a and a C-terminally truncated form, GRIF-1b. GRIF-1 mRNA has a wide distribution with a major transcript size of 6.2 kb. GRIF-1a protein is only expressed in excitable tissues, i.e. brain, heart, and skeletal muscle major immunoreactive bands of M r ϳ 115 and 106 kDa and, in muscle and heart only, an additional 88-kDa species. When expressed in human embryonic kidney 293 cells, GRIF-1a yielded three immunoreactive bands with M r ϳ 115, 106, and 98 kDa. Co-expression of GRIF-1a and ␣1␤2␥2 GABA A receptors in mammalian cells revealed some co-localization in the cell cytoplasm. Anti-FLAGagarose specifically precipitated GRIF-1 FLAG and GABA A receptor ␤2 subunits from human embryonic kidney 293 cells co-transfected with GRIF-1a FLAG and ␤2 subunit clones. Further, immobilized GRIF-1-(8 -633) specifically precipitated in vitro GABA A receptor ␣1 and ␤2 subunit immunoreactivities from detergent extracts of adult rat brain. The respective GABA A receptor ␤2 subunit/GRIF-1 binding domains were mapped using the yeast two-hybrid reporter gene assays. A possible role for GRIF-1 as a GABA A receptor ␤2 subunit trafficking factor is proposed.
␥-Aminobutyric acid type A (GABA A ) 1 receptors, fast-acting ligand-gated chloride ion channels, are the major inhibitory neurotransmitter receptors in the mammalian central nervous system. There are multiple GABA A receptor subunit genes encoding the ␣1-6, ␤1-3, ␥1-3, ␦, ⑀, , and subunits. These subunits co-assemble in different pentameric combinations throughout development to form functional receptors (reviewed in, e.g., Ref. 1). The major GABA A receptor subtype in adult brain is composed of ␣1, ␤2/3, and ␥2 subunits with a probable stoichiometry of 2␣1, 2␤2/3, 1␥2. This subunit combination is expressed predominantly at the synapse, whereas other subunit combinations have different subcellular localizations, e.g. ␦ subunit-containing GABA A receptors are localized extrasynaptically in cerebellar granule cells (2) and ␣2 subunit-containing receptors are found uniquely at axon initial segments in hippocampal pyramidal cells (3) . By analogy with other neurotransmitter receptor systems, it is thought that GABA A receptor-associated proteins exist that determine receptor subcellular localization, mediate receptor clustering, and regulate receptor activity. For example, Sigel and colleagues (4) reported co-purification of ␣1 subunit-containing GABA A receptors and several proteins including actin and tubulin. Some of these proteins were identified as GABA A receptor-tubulin complex-associated proteins, thus showing a link between the receptors and the cytoskeleton. One of these proteins, GABA A receptor-tubulin complex-associated protein 34, was shown to be a novel serine kinase with specificity for ␤3 subunits (5) . More recently, the same group identified this protein as the mitochondrial, multifunctional protein, gC1q-R (6). The glycine receptor-associated protein, gephyrin, has also been implicated in the synaptic clustering of GABA A receptors, although a direct association between the two proteins has not been shown (reviewed in Refs. 7 and 8). Knock-out ␥2 (Ϫ/Ϫ) mice have a parallel deficiency in both gephyrin and clustered post-synaptic GABA A receptors (9) . More recently, the yeast two-hybrid system has been used to identify GABA A receptor-associated proteins. Proteins identified via this route include GABARAP (GABA A receptor-associated protein), Plic-1 (GABA A receptorassociated ubiquitin-like protein), and microtubule-associated protein 1B (MAP-1B). MAP-1B was shown to link GABA C receptors to the cytoskeleton at retinal synapses (10) . GABARAP is a 13.9-kDa microtubule-associated protein that binds specifically to the ␥2 subunit and promotes the clustering of GABA A receptors expressed in Qt-6 quail fibroblasts (11, 12) . Differences in functional properties were reported between the clustered and unclustered receptors (12) . It has also recently been reported to mediate intracellular transport of GABA A receptors by virtue of its specific interaction with N-ethylmaleimide-sensitive factor (13) . Plic-1 (formerly GRUB1) is a GABA A receptor-associated ubiquitin-like protein that binds the ␣1 subunit and plays a role in the stabilization of cell surface receptors (14, 15) .
We have used the yeast two-hybrid system to identify GABA A receptor-associated proteins. Using the GABA A receptor ␤2 intracellular loop (␤2-IL) as a bait, we have discovered a novel protein GABA A receptor interacting factor (GRIF-1) that is expressed predominantly in excitable tissues. The characterization of this protein is reported in this paper.
EXPERIMENTAL PROCEDURES

Constructs
The IL of the GABA A receptor ␤2 subunit was selected as a bait in a yeast two-hybrid screen. The coding sequence of the human ␤2-IL (aa 301-426; Ref. 16 ) was amplified by the polymerase chain reaction (PCR) utilizing primers that contained EcoRI and BamHI restriction enzyme sites. The product was subcloned into the EcoRI and BamHI sites of the bait vector, pAS2-1 (Matchmaker Two-Hybrid System 2, CLONTECH, Palo Alto, CA). Likewise, constructs encoding Gal4 DNA binding domain (BD) fusion proteins of the rat GABA A receptor ␣1 (aa 304 -384), ␤1 (aa 293-426), ␤3 (aa 293-426), and ␥2 L (aa 317-411) subunit ILs and ␤2-TM3/IL/TM4 (aa 292-439) and ␤2-IL/TM4 (aa 272-439) in pAS2-1 were prepared. The authenticity of all constructs was verified by nucleotide sequencing utilizing ABI PRISM dye terminator chemistry on an ABI 310 Genetic Analyzer and immunoblotting of respective yeast protein extracts. All bait constructs tested negative for auto-activation of reporter gene activity in the yeast two-hybrid reporter strains, CG1945 and AH109.
Yeast Two-hybrid Screening
Yeast cultures were grown on standard solid or in liquid media using either YPAD (yeast, peptone, adenine, dextrose; 2% (w/v) peptone, 1% (w/v) yeast extract, 2% (w/v) glucose, 0.003% (w/v) adenine) or SD (synthetic dropout medium; 0.67% (w/v) yeast nitrogen base (BD PharMingen, Cowley, Oxford, UK), 2% (w/v) glucose, 1ϫ dropout supplement (CLONTECH) as appropriate for the selection involved). All transformations were performed using the lithium acetate/polyethylene glycol method (17) . Saccharomyces cerevisiae strain CG1945 (MATa, 112, cyh r 2, LYS2::GAL1 UAS -GAL1 TATA -HIS3, URA3::GAL4 17-mer (3x) -CYC1 TATA -lacZ) was used to screen a rat brain cDNA library (in vector, pGAD10; CLONTECH) with pAS2-1␤2-IL as a bait. Resulting colonies were assessed for reporter gene activation by initial nutritional selection (growth on SD ϪHis) and subsequent lacZ activity assay. lacZ activity was determined by filter lift analysis, including appropriate positive and negative interaction controls. Clones encoding putative interacting proteins were isolated and analyzed following standard procedures (18) . Their association with the GABA A receptor ␤2-IL was verified by reconstitution assays with a selection of different bait constructs introduced by both yeast mating assays and repeated co-transformation.
Quantification of ␤-Galactosidase Reporter Gene Activity
␤-Galactosidase reporter gene activity was determined by liquid culture assays using o-nitrophenyl ␤-D-galactopyranoside as substrate according to protocols provided by CLONTECH. Briefly, double transformants of yeast strain AH109 expressing the appropriate GAL4 BD and AD fusions were grown overnight in selective medium followed by expansion to mid-log phase in YPAD medium. Cells were harvested, washed once with Z-buffer (0.1 M sodium phosphate, pH 7.0, 1 mM KCl, 1 mM MgSO 4 ), and resuspended in 0.2 of the original volume in Z-buffer. For each sample, 100 l of cell suspension was subjected to three freeze-thaw cycles in liquid nitrogen, and then 0.96 ml of Z-buffer containing 38 mM ␤-mercaptoethanol and 0.16 mM o-nitrophenyl ␤-Dgalactopyranoside was added. The mixture was incubated at 30°C for 10 min to overnight depending on the time taken for color development. Reactions were stopped by the addition of 1 M Na 2 CO 3 (0.4 ml), cellular debris removed by centrifugation, and OD at ϭ 420 nm measured against Z-buffer blanks. Values of ␤-galactosidase activity were normalized to the cell density of the expansion culture and then expressed as a percentage of wild-type Gal4p.
Cloning of the Entire GRIF-1 cDNA and Sequence Analysis
The full-length GRIF-1 cDNA was obtained by a combination of cDNA library screening and rapid amplification of cDNA ends (RACE).
The clone resulting from the initial yeast two-hybrid screen was labeled with ␣-32 P by the random primer method (19) . It was used to screen a rat brain cDNA library by colony hybridization. DNA from positive clones were sequenced and used for subsequent screenings. In addition, 5Ј-and 3Ј-RACE was performed on rat brain cDNA using the Marathon cDNA amplification system (CLONTECH). RACE products were TAsubcloned into pCR2.1 (Invitrogen, Groningen, The Netherlands) for further analysis. Cloned fragments and RACE PCR products were sequenced as described. The GRIF-1 contig was assembled using Lasergene software (DNAstar Inc., Madison, WI). The assembled cDNA and deduced amino acid sequence were subjected to analysis by a variety of predictive algorithms. BLAST searches were conducted against GenBank TM and EMBL data bases. Procrustes (20) analysis and a selection of hits obtained by BLAST searches against the human subset of GenBank TM and EMBL sequences were used to assemble the cDNA sequence of the human homologue of GRIF-1. Sequence alignments were performed with CLUSTAL. Structure predictions used a variety of publicly available resources such as psort (Ref. 21 ; psort. nibb.ac.jp) and SMART (Ref. 22 ; smart.embl-heidelberg.de).
GRIF-1 mRNA Expression and mRNA Analysis
Northern Blotting-GRIF-1 cDNA fragments were radiolabeled with ␣-
32
P by a standard random priming method and used to probe a rat multiple tissue Northern blot (CLONTECH). Hybridization was carried out using ExpressHyb solution according to the manufacturer's instructions. After final washing (0.1ϫ SSC, 0.1% (w/v) SDS, 50°C), the blot was exposed to imaging plates for 20 h. Plates were read with a PhosphorImager (Amersham Biosciences, Aylesbury, Bucks., UK) and analyzed using ImageQuant software.
Reverse Transcription-PCR Analysis-A set of PCR reactions with primers spanning the whole GRIF-1 coding region was employed to screen for alternative spliced isoforms in rat brain. Amplification was usually performed in a total volume of 25 l containing 1ϫ PCR buffer (10 mM Tris-HCl, pH 9.0, 50 mM KCl, 0.1% (v/v) Triton X-100; Promega Corp., Madison, WI), 1.5 mM MgCl 2 , 0.5 mM each dNTP, 0.2 M each primer, 0.5 unit of Taq DNA polymerase, and 0.5 l of cDNA (CLON-TECH). Reactions were cycled through a profile consisting of 5 min of initial denaturation at 94°C, followed by 30 cycles consisting each of 25 s at 94°C, 25 s at 55°C, and 1 min at 72°C, followed by a final extension step of 7 min at 72°C on a Hybaid OmniGene thermal cycler. PCR products were separated by flatbed agarose gel electrophoresis, visualized by ethidium bromide staining, and analyzed using the EDAS120 imaging system (Eastman Kodak Co.).
Generation of Anti-GRIF-1 Antibodies
A fusion protein was used to generate anti-GRIF-1 polyclonal antibodies in rabbits. For the fusion protein, the DNA encoding GRIF-1-(8 -633), i.e. the original library clone, was subcloned into the bacterial expression vector, pTrcHisB (Invitrogen). BL 21 Escherichia coli transformed with the recombinant pTrcHisBGRIF-1-(8 -633) were cultured overnight, diluted 1:50 with LB and grown at 37°C until mid-log phase (OD ϭ 600 nm ϭ 0.6). Expression of the poly(His)-GRIF-1-(8 -633) fusion protein was induced by the addition of 1 mM isopropyl-␤-D-thiogalactopyranoside for 3-5 h at 30°C. The E. coli culture was centrifuged at 5000 ϫ g for 10 min at 4°C, the supernatant discarded, and the pellet resuspended in lysis buffer, which was 20 mM sodium phosphate, pH 7.8, 6 M guanidine hydrochloride, 500 mM sodium chloride (10 ml) at 37°C. The lysate was stirred gently at room temperature for 10 min followed by sonication (three 5-s pulses at high intensity) on ice. The cleared suspension was centrifuged at 3000 ϫ g for 15 min at 4°C and the poly(His)-GRIF-1-(8 -633) fusion protein purified from the supernatant by Ni 2ϩ affinity chromatography using ProBond columns exactly as per the manufacturer's instructions (Invitrogen) followed by preparative sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The purified fusion protein, M r ϳ 70 kDa, was used to generate anti-GRIF-1-(8 -633) polyclonal antibodies in rabbits. Anti-GRIF-1-(8 -633) antibodies were affinity-purified by GRIF-1-(8 -633)-Ni 2ϩ -agarose affinity chromatography prior to use (23) .
Immunoblotting SDS-PAGE was carried out using 10% polyacrylamide slab gels under reducing conditions. Samples were prepared using the chloroform/ methanol method of protein precipitation, and immunoblotting was carried out as previously described using affinity-purified anti-GABA A receptor ␣1 subunit (24), anti-␤2 subunit (25) , affinity-purified anti-GRIF-1-(8 -633), and anti-neuron-specific ␥,␥Ј-enolase (NSE) antibodies in conjunction with the enhanced chemiluminescence (ECL) Plus Western blotting detection system (Amersham Biosciences) for the detection of immunoreactive species. Anti-rabbit and mouse immunoglobulin horseradish peroxidase-linked whole antibodies (Amersham Biosciences) were used at a final dilution of 1:2000. Where applicable, immunoblots were quantified by densitometry using a Personal Densitometer and ImageQuant (Amersham Biosciences) in the linear range of the film.
Subcellular Fractionation of Rat Tissues
Tissues from rat forebrain, cerebellum, liver, kidney, heart, and spleen were each homogenized in nine volumes of homogenizing buffer (20 mM Tris-HCl, pH 7.4, 0.25 M sucrose, containing benzamidine (1 g/ml), bacitracin (1 g/ml), soybean trypsin inhibitor (1 g/ml), chicken egg trypsin inhibitor (1 g/ml), and phenylmethylsulfonyl fluoride (1 mM)) at 4°C using a hand-held glass-glass homogenizer. Skeletal and cardiac muscle was removed, minced using scissors, and homogenized using an Ultra-Turrax (six 10-s pulses at medium speed) followed by homogenization as above. Homogenates were centrifuged at 600 ϫ g for 10 min at 4°C. The supernatants were collected and the P1 nuclear pellets re-homogenized in three volumes of homogenizing buffer and re-centrifuged at 600 ϫ g for 10 min at 4°C. Both supernatants were combined and centrifuged at 100,000 ϫ g for 40 min at 4°C to yield the soluble (S) and P2 membrane fractions. The P1 and P2 pellets were re-suspended in homogenizing buffer and stored at Ϫ20°C until use.
Co-expression of GABA A Receptors and GRIF-1a in Human Embryonic Kidney (HEK) 293 Cells
The cDNA encoding the full-length GRIF-1a was obtained by PCR from rat brain cDNA and subcloned into both the mammalian expression vectors, pCIS and pCMV-Tag4 (Stratagene, La Jolla, CA). The latter yielded a C-terminal FLAG-tagged GRIF-1. HEK 293 cells were cultured and transfected in 250-ml flasks using the calcium phosphate method as described previously (26) . Cells were transfected with pCIS GRIF-1a or pCMV-Tag4GRIF-1a alone (10 g of DNA) or with the GABA A receptor clones pCDM8␣1 (bovine), pCIS␤2 (rat), pCDM8␥2L (bovine), and pCISGRIF-1 or pCMV-TagGRIF-1 in a 1:1:1:1 ratio with a total of 10 g of DNA. Cells were harvested 24 -48 h following transfection and analyzed by immunoblotting. For immunocytochemical studies, transfections were carried out by the calcium phosphate method on HEK 293 cells adhered to poly-L-lysine-coated cover slips. 
Co-immunoprecipitation Assays
HEK 293 cells were co-transfected with pCMV-Tag4GRIF-1a ϩ pCIS␤2; pCIS␤2 ϩ pCIS, pCMV-Tag4GRIF-1a ϩ pCDM8␣1, or pCMVTag4GRIF-1a ϩ pCIS (1:1 ratio with 10 g of total DNA). Cells were harvested 48 h after transfection and solubilized for 1 h at 4°C with 10 mM HEPES, 150 mM NaCl, 5 mM EDTA, 5 mM EGTA, 1% (v/v) Triton X-100, and protease inhibitors as described above under "Subcellular Fractionation of Rat Tissues." The solubilized material was collected by centrifugation at 100,000 ϫ g, diluted 1:3 in 10 mM HEPES, 50 mM NaCl, 16 mM KCl, 1 mM EDTA ϩ protease inhibitors, and incubated (8 ml) with anti-FLAG M2-agarose (30 l; Sigma, Poole, Dorset, UK) for 1 h at 37°C. Samples were centrifuged for 20 s at 3000 ϫ g and the pellet washed with two 0.5-ml (17 volumes) amounts of 10 mM HEPES, 75 mM NaCl, 12.5 mM KCl, 2 mM EDTA, 1.25 mM EGTA ϩ protease inhibitors, 0.25% (v/v) Triton X-100, followed by 17 volumes of the same buffer but with a Triton X-100 concentration of 1% (v/v). The pellets were collected by centrifugation as above and analyzed by immunoblotting.
In Vitro Protein Interaction Assay
BL 21 cells were transformed with either pTrcHisBGRIF-1-(8 -633) or the empty, pTrcHisB expression vector and the respective bacterial cell lysates prepared as detailed under "Generation of Anti-GRIF-1 Antibodies." ProBond resin (Invitrogen) was washed three times with seven volumes of distilled H 2 O followed by seven volumes of denaturing binding buffer, which was 20 mM sodium phosphate, pH 7.8, 8 M urea, 500 mM NaCl. The resin (25 l) was incubated with either the pTrcHis-GRIF-(8 -633) lysate, the pTrcHis lysate or lysis buffer (1 ml) for 10 min at 20°C. Each resin was then washed two times with 14-volumes native binding buffer, which was 20 mM sodium phosphate, pH 7.8, 500 mM NaCl. A detergent-solubilized rat forebrain P2 extract was prepared by re-suspension of a 100,000 ϫ g P2 pellet in 10 mM HEPES, pH 7.5, 50 mM KCl, 1 mM EDTA, 1% (v/v) Triton X-100, benzamidine HCl (1 g/ml), bacitracin (1 g/ml), soybean trypsin inhibitor (1 g/ml), chicken egg trypsin inhibitor (1 g/ml), and phenylmethylsulfonyl fluoride (1 mM) to a concentration of 3 mg of protein. Solubilization was carried out for 1 h at 4°C and the detergent extract cleared by centrifugation at 100,000 ϫ g for 40 min at 4°C. The derivatized resins were incubated with the solubilized P2 membrane proteins diluted 1:3 with 10 mM HEPES, pH 7.5, 17 mM KCl, with the protease inhibitors as above to give final concentrations of 0.25% (v/v) Triton X-100 and 25 mM KCl (1 ml of 1 mg/ml protein) overnight at 4°C. The supernatant was removed by centrifugation of the resins at 200 ϫ g for 10 s at 4°C. Each resin was washed once with 40 volumes of 20 mM sodium phosphate, pH 7.8, 500 mM NaCl., 0.05% (v/v) Triton X-100. The bound proteins were extracted with SDS-PAGE sample buffer (50 l), heated for 5 min at 
summary of the specificity of the GRIF-1/GABA A receptor subunit interactions in the yeast two-hybrid system
The yeast strain AH109 was co-transformed with bait and fish constructs and transformants grown on SD ϪTrp, ϪLeu, ϪHis, ϪAde, i.e. SD Ϫ 4 plates. Colonies were patched to either SD Ϫ 4 plates and ␤-galactosidase activity measured by filter lift assays or alternatively to Ϫ 4 plates with agarose X-␣ Gal overlay to measure Me1 activity all as described under "Experimental Procedures." The strength of the bait and fish interactions are expressed as a percentage of wild-type Gal4 protein transformants which were determined using the yeast strain, AH109. ND, not determined. 
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100°C, and the supernatants analyzed by quantitative immunoblotting using affinity-purified anti-␤2 fragment 381-395 (25), anti-␣1 fragment 413-429 (27) , and anti-NSE antibodies (Affiniti Research Products Ltd., Mamhead, Exeter, UK). The results were analyzed by paired Student's t test.
Determination of the GRIF-1 and ␤2-IL Interacting Domains
A series of GRIF-1 fragments were constructed by either standard subcloning techniques from the isolated library clone, C3, or PCR amplification. These were subcloned into pGAD10, pACT2, or pGADT7 (CLONTECH) to yield Gal4 AD fusion proteins. Similarly, fragments of the ␤2-IL (aa 303-427, 303-370, 355-427, 371-427, 303-394, 324 -394, and 324 -427) were fused to the GAL4 BD in pAS2-1. The yeast strain AH109 (MATa, 112, gal4⌬ , gal80D, LYS2::GAL1 UAS -GAL1 TATA -HIS3, GAL2 UAS -GAL2 TATA -ADE2, URA3::MEL1 UAS -MEL1 TATA -lacZ; CLONTECH) was transformed with pair-wise combinations of ␤2-ILBD and GRIF-1AD fusions. The interaction between pairs of proteins was assayed by nutritional selection on SD Ϫ4 (ϪHis, ϪTrp, ϪAde, ϪLeu) plates as well as ␤-galactosidase and ␣-galactosidase (Mel1) activity. ␣-Galactosidase activity was determined by overlaying the plates with X-␣ Gal-top agar (0.4% (w/v) low melting point agarose, 0.001% (w/v) X-␣ Gal (Melford Laboratories, Cambridge, UK) in Z-buffer. Coloration usually occurred within 3-6 h.
RESULTS
Identification of a Novel Protein That
Interacts with the GABA A Receptor ␤2 Subunit-The GABA A receptor ␤ subunits have been reported to determine the subcellular localization of ␣␤␥ receptors (28) . The ␤2 subunit is the most abundantly expressed of the ␤ isoforms in adult brain (see, e.g., Refs. 29 and 30). Therefore, the GABA A receptor ␤2-IL was selected as a bait to identify ␤ subunit interacting proteins that may function as targeting or clustering molecules. A yeast two-hybrid cDNA library screen of 1.5 ϫ 10 6 independent transformants with the GABA A receptor ␤2-IL as the bait yielded initially 36 positively growing clones of which one, C3, showed lacZ reporter gene activity. The plasmid isolated contained a 1.8-kb insert with an in-frame fusion encoding 626 aa. Re-transformation of this clone into yeast strain, AH109, with a variety of different GABA A receptor subunit IL bait constructs, i.e. ␣1, ␤1, ␤3, and ␥2-ILs, showed that C3 interacted specifically with the ␤2-IL (Table I) . Further, C3 did not yield reporter gene activity when alternative ␤2-IL constructs that incorporated either both TM3 and TM4, i.e. ␤2-TM3/ILTM4, or TM4 only, i.e. ␤2-IL/TM4, were used as baits (Table I) . Quantification of lacZ reporter gene activity revealed a relative strength of the C3/␤2-IL interaction of ϳ1.5% relative to 100% of the pCL-1 (Gal4p wildtype) positive control ( Table I) .
The cDNA Encodes a Novel Protein That Is Conserved in Mammalian Evolution-Nucleotide sequencing revealed that 
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C3 contained an open reading frame of novel sequence fused in-frame to the GAL4 activation domain. The full-length cDNA of the protein was obtained by cDNA library screening using the C3 probe in conjunction with 5Ј-and 3Ј-RACE. The assembled cDNA sequence (3641 bp) contains an open reading frame of 2739 bp predicting a protein of 913 aa residues, a calculated molecular mass of 102 kDa, and an acidic pI ϭ 5.14. Within the protein, the original two-hybrid interacting fragment (C3) extends from aa 8 to 633. We have called the protein, GRIF-1, for GABA A receptor interacting factor. The nucleotide and deduced amino acid sequence of GRIF-1 are shown in Fig. 1 . Expression of a transcript of the predicted sequence was verified by PCR amplification from adult rat brain cDNA utilizing a variety of oligonucleotide primers (results not shown). Using the primers cs2150 and ca3119, two PCR products were obtained (Fig. 1) . Nucleotide sequencing of the PCR products revealed a deletion of 107 bp in the smaller product that altered the reading frame of GRIF-1. Thus, an alternative, C-terminally truncated splice form of GRIF-1 with 672 aa was identified and termed GRIF1b, with the original 913-aa protein now denoted GRIF-1a. Both GRIF-1a and GRIF-1b were shown to associate with the GABA A receptor ␤2-IL in the yeast two-hybrid assay. Quantitative analysis of the resultant reporter gene activity showed that GRIF-1a and the original C3 clone yielded a similar strength of interaction with ␤2-IL ( Table I) .
Analysis of the GRIF-1 deduced amino acid sequence revealed a hydrophilic protein with no predicted transmembrane domains and no hydrophobic signal peptide. Structure prediction analysis indicated a high ␣-helical content (31) and the presence of a coiled-coil identified by both the Lupas and the paircoil algorithms (32, 33) . The GRIF-1 aa sequence contains consensus sequences for protein kinase A phosphorylation at aa 384 and 726 and tyrosine kinase at aa 273, as well as 16 potential protein kinase C and 15 potential casein kinase II phosphorylation sites. There is also a proline-rich domain with 29% proline residues between aa 756 and 793 (Fig. 2) .
Data base searches revealed that GRIF-1 has no significant homology with proteins of known function. However, amino acid sequence similarity was found between GRIF-1 and two human genes of unknown function identified in a brain gene cloning project, a chromosome 2 gene, KIAA0549 (ϳ78% over 469 aa; Ref. 34 ) and KIAA1042 (ϳ45% identity over 913 aa; Ref. 35 ). Homology of ϳ47% over 297 aa was also found with the rat huntingtin-associated protein (rHAP-1; Ref. 36) . The similarity between GRIF-1, HAP-1 and the related protein, HAP-like protein, was restricted to the N terminus in a region that coincided with the first predicted coiled-coil domain (Fig.  2) , whereas it became evident that GRIF-1 and KIAA0549 are species orthologues.
Procrustes analysis of GRIF-1 versus the draft human genome sequence of chromosome 2 predicted the existence of a gene comprising at least 15 exons and extended the reading frame of KIAA0549 toward its N terminus. From these results, in conjunction with a number of expressed sequence tag sequences (dbEST accession nos. AA338224, AA075951, AW952742, and BE070051), the full-length KIAA0549 cDNA sequence was assembled. The deduced cDNA encodes a 914-amino acid protein with an overall ϳ88% amino acid sequence identity to GRIF-1. The expression of this novel sequence was verified by its PCR amplification from human fetal brain cDNA (data not shown). This cDNA corresponds to one recently reported by Hadano et al. (37) , ALS2CR3, with the exception of one conservative amino acid change, K55R (Fig. 2) . ALS2CR3 was shown to contain 16 exons (37) . Functional equivalence between GRIF-1 and full-length KIAA0549 was demonstrated by a similar strength of interaction with the GABA A receptor ␤2-IL in the yeast two-hybrid reporter strain, AH109 (Table I) . Furthermore, the deletion found in the GRIF-1b isoform was found to be equivalent to exon 15 of the human ALS2CR3/ KIAA0549 gene.
More recently, similarity was found between GRIF-1 and the Drosophila melanogaster gene product, CG13777 (also known as LD313316p and mltLD8CG13777; GenBank TM accession nos. AE003616, AY051825, and AY038001, respectively) and the Macaca fascicularis hypothetical protein, BAB41149 (Genpept accession no. AB060210). Using expressed sequence tag data (AK014647) as well as the Celera discovery system, partial sequences of the mouse orthologues of both KIAA0549 (ALS2CR3)/GRIF-1 and KIAA1042 were identified. Blockmaker and MEME analysis (38) identified conserved regions and predicted a similar domain structure for all these proteins. The conserved domain structure includes the N-terminal coiled-coil region and two motifs outside this region, namely GRIF-1 aa 30 -60, with a consensus sequence: (Fig. 2) . Thus GRIF-1 is a member of a new protein family with as yet, two known members in mammals and a single homologue in D. melanogaster. GRIF-1 (rat), KIAA0549 (ALS2CR3) (human), and mCP 20802/mCP20839 (mouse) are a group of species orthologues as are KIAA1042 (human), BAB41149 (M. fascicularis), and mCP13834 (mouse).
TDVC(S/N)(N/ S)EDLPEVE(I/L)(V/I)SLLEEQLPQYKLRVD(S/T)(L/I)(F/Y)(L/ G)Y and aa 553-595, consensus sequence PEKLQIVKP-LEGS(Q/A)TLHHWQQLAQP(H/N)LG(G/T)ILDPRRGV(I/V) TKGF(S/T)
Tissue Distribution of GRIF-1 mRNA and GRIF-1 Protein-A rat multiple tissue Northern blot probed with [ 32 P]GRIF-1 revealed a major hybridizing transcript of 6.2 kb, which was present in all tissues tested except testis, where a transcript of 2.9 kb was found (Fig. 3) . The rank order of expression was spleen Ͼ heart Ͼ lung Ͼ brain Ͼ kidney ϳ skeletal muscle. A minor transcript of 4.2 kb was also detectable with highest expression in the spleen. Electrophoretic separation of 3Ј-RACE products revealed two major species of 4.2 and 1.9 kb, which correspond in size to the 6.2-and 4.2-kb transcripts identified in the Northern blot (Fig. 3) . These two transcripts are most likely derived by alternative use of polyadenylation sites in the 3Ј-untranslated region.
Soluble, P1 nuclear fractions and P2 membrane fractions P by random priming as described under "Experimental Procedures." Major transcripts of 6.2 kb were present in all tissues except testes, where the major transcript was 2.9 kb. A minor 4.2-kb hybridizing species was also present, with the highest expression being found in the spleen. B, rat brain cDNA was subject to 3Ј-RACE using the oligonucleotide primer cs2150 and the Marathon adaptor AP1 as described under "Experimental Procedures." Flatbed agarose gel electrophoresis yielded two products of 1.9 and 4.2 kb.
were prepared from all tissues used in the Northern blot except lung. These were analyzed by immunoblotting using affinitypurified anti-GRIF-1-(8 -633) antibodies. The results are shown in Fig. 4 . It can be seen that, in all subcellular fractions of forebrain, cerebellum and heart, the antibodies recognized two bands with M r ϳ 115,000 (major) and M r ϳ 106,000 (n ϭ 3). In skeletal muscle, a single immunoreactive species with M r ϳ 115,000 was found in the P1 and soluble fractions; this band was also present in the soluble fraction of testes. An additional immunoreactive band with M r ϳ 88,000 was observed in heart P1 and P2 fractions, in P1 for muscle and P2 for forebrain. A molecular weight of 115,000 is in the range of that predicted for a 913-aa protein. Importantly, the band is coincident with the major immunoreactive species obtained following expression of the full-length GRIF-1 in HEK 293 cells. The lower molecular mass M r ϳ 106,000 band, which is also observed in the transfected cells, may be a proteolytic product. The M r ϳ 88,000 immunoreactive species expressed predominantly in the heart has a molecular size consistent with the predicted size of the GRIF-1b variant.
In Vitro Protein Interaction Assay-To demonstrate that GRIF-1 can associate with ␤2 subunit-containing GABA A receptors, in vitro protein interaction assays were carried out. Thus, poly(His)-GRIF-1-(8 -633) immobilized on Ni 2ϩ -agarose, poly(His)-Ni 2ϩ -agarose, or Ni 2ϩ -agarose was each incubated with Triton X-100 detergent extracts of rat forebrain and associated proteins identified by precipitation followed by immunoblotting. The results are shown in Fig. 5 . It can be seen that poly(His)-GRIF-1-(8 -633)-Ni 2ϩ -agarose specifically precipitated GABA A receptor ␤2 and ␣1 subunit immunoreactivities. No immunoreactivities were precipitated by the resin alone Some ␤2 and ␣1 immunoreactivity was always associated with the control poly(His)-Ni 2ϩ -agarose, but the respective immunoreactivities were always greatest for precipitation by poly(His)-GRIF-1-(8 -633)-Ni 2ϩ -agarose. As an additional control, the agarose pellets were probed with anti-NSE antibodies. No anti-NSE immunoreactivity was detected in either the control poly-(His)-Ni 2ϩ -agarose or the poly(His)-GRIF-1-(8 -633)-Ni 2ϩ -agarose pellets (Fig. 5C ). The relative intensities of the ␣1 and ␤2 immune signals between the control poly(His)-Ni 2ϩ -agarose and the test, poly(His)-GRIF-1-(8 -633)-Ni 2ϩ -agarose were found to vary with assay incubation conditions. Optimal results were obtained by reducing the concentration of Triton X-100 to 0.25% (v/v). The results of the pull-down assays in the presence of 0.5 and 0.25% (v/v) Triton X-100 were analyzed by quantitative immunoblotting with the following results, which are expressed as the -fold increase in immunoreactivity precipitated by poly(His)-GRIF-1-(8 -633)-Ni 2ϩ -agarose with respect to that precipitated by poly(His)-Ni 2ϩ -agarose: 0.5% Triton X-100, 2.9 Ϯ 0.5 (␤2) (n ϭ 5; p Ͻ 0.01) and 1.6 Ϯ 0.2 (␣1) (n ϭ 4; p Ͻ 0.05); 0.25% Triton X-100, 4.0 Ϯ 0.7 (␤2) (n ϭ 4; p Ͻ 0.03) and 1.9 (␣1) (n ϭ 2). The ratio for the -fold increase in immunoprecipitation for ␤2/␣1 was 1.8 (0.5% Triton X-100) and 2.1 (0.25% Triton X-100). Thus, GRIF-1-(8 -633) does interact with both ␣1 and ␤2 GABA A receptor subunits, suggesting co-association with assembled ␤2 subunit-containing GABA A receptors. It was noted, however, that the percentage of ␤2 subunit immunoreactivity precipitated was always significantly higher than that found in ␣1 (see "Discussion").
Expression of GRIF-1 in HEK 293 Cells-Untransfected HEK 293 cells showed no anti-GRIF-1 immunoreactivity when analyzed by either immunoblotting or immunocytochemistry (Fig. 6A ). As described above, when HEK 293 cells were transfected with either pCISGRIF-1a or pCMVTag4GRIF-1a FLAG, a major band with M r ϳ 115,000 was recognized in whole cell homogenates by both anti-GRIF-1-(8 -633) or anti-FLAG antibodies (Fig. 4) ; two minor bands with M r values of 105,000 and 98,000 were also detected. All three immunoreactive bands were detected in the P1, P2, and soluble cell cytoplasm fraction (results not shown). In permeabilized, transfected cells, GRIF-1 or GRIF-1 FLAG expressed alone had a diffuse, intracellular localization (Fig. 6B) . This was in contrast to the pattern ob- FIG. 4 . Subcellular and tissue distribution of GRIF-1 protein by immunoblotting. Rat tissues were homogenized and subjected to subcellular fractionation to yield the P1 (nuclear fraction), the P2 (membrane fraction), and S (soluble) proteins. Samples (10 g of protein/gel lane) were analyzed by immunoblotting using affinity-purified anti-poly(His)-GRIF-1-(8 -633) fusion protein antibodies all as described under "Experimental Procedures." A, B, and C are immunoblots of P1, P2, and soluble fractions, respectively, with tissues as indicated. The last lane of each blot contains pCISGRIF-1-transfected HEK 293 cell homogenates. A major immunoreactive band with M r ϳ 115,000 was found in P1, P2, and S fractions for forebrain, cerebellum, heart, skeletal muscle, in HEK cells transfected with pCISGRIF-1a and in the S fraction of testes (n ϭ 3-10). In P1 and P2 membrane preparations of rat forebrain, cerebellum, and heart, an additional band with M r ϳ 106,000 (n ϭ 11) was found. HEK 293 cell homogenates transfected with GRIF-1a showed two additional bands with M r values ϳ 106,000 and 98,000. Heart and skeletal muscle P1 fractions both expressed a M r ϳ 88,000 immunoreactive species. Molecular size markers (ϫ 10 3 kDa) are shown on the right.
served for HEK 293 cells expressing ␣1␤2␥2 GABA A receptors probed with the anti-GABA A receptor ␤2/␤3 subunit monoclonal antibody, bd-17. Here, the immunoreactivity showed a punctate, plasma membrane localization in addition to some cytoplasmic staining (Fig. 6C) . Fig. 6 (D-F) shows the distribution of GRIF-1a and ␤2 subunit immunoreactivity when GRIF-1 FLAG was co-expressed with the GABA A receptor ␣1, ␤2, and ␥2 subunit clones. The ␤2 subunit is again localized predominantly to the plasma membrane, but some intracellular staining is evident. For GRIF-1a, immunoreactivity is still mostly distributed in the cell cytoplasm. Merging of the GRIF-1a and ␤2 subunit immunoreactivities revealed some areas of co-localization within the cell cytoplasm (Fig. 6F) .
Co-immunoprecipitation Assays-To substantiate co-association of GRIF-1 and GABA A receptor ␤2 subunits, HEK 293 cells were co-transfected with pCMVTag4GRIF-1a FLAG and pCIS␤2 and immunoprecipitation assays carried out. The results are shown in Fig. 7 . In Fig. 7A , it can be seen that GRIF-1, M r ϳ 115,000, is present in the immune pellets following incubation with anti-FLAG M2-agarose only when cells were transfected with the GRIF-1 clone. This confirms the immunocytochemical studies, i.e. HEK 293 cells have no detectable endogenous GRIF-1. GABA A receptor ␤2 subunit immunoreactivity was also precipitated by anti-FLAG M2-agarose in the presence of GRIF-1 (Fig. 7B) . Anti-␤2 381-395 antibodies recognized four molecular weight species with M r in the range of 48 -58 kDa in cells co-transfected with GRIF-1 and GABA A receptor ␤2 subunit clones and precipitated with anti-FLAG M2-agarose. An additional immunoreactive band with M r ϳ 26,000 was detected by the anti-␤2 antibodies; however, this ␣1 and ␤2 subunits to GRIF-1-(8 -633) using immobilized  GRIF-1-(8 -633) affinity chromatography purification. The fusion proteins, pTrcHis and pTrcHis-GRIF-1-(8 -633), were generated in E. coli and immobilized to washed and equilibrated Ni 2ϩ -agarose. Triton X-100 extracts (1 mg of protein; 1 ml) of rat brain were incubated with Ni 2ϩ -agarose, pTrcHis-Ni 2ϩ -agarose, or pTrcHis-GRIF-1-(8 -633) -Ni 2ϩ -agarose overnight at 4°C in the presence of 0.25% (v/v) Triton X-100 and 25 mM KCl. Agarose pellets were collected by centrifugation and analyzed by quantitative immunoblotting using anti-␤2 381-395 (A), ␣1 413-429 (B), and neuron-specific enolase (C) antibodies all as described under "Experimental Procedures." The gel layout is identical for each blot. 
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was the result of the anti-FLAG monoclonal antibody because it was present in control experiments when immunoprecipitation was carried out from buffer solution (Fig. 7B) . Further specificity controls showed that ␤2 subunit immunoreactivity was not precipitated in the absence of GRIF-1 (Fig. 7B) . HEK 293 cells co-transfected with GRIF-1 and GABA A receptor ␣1 subunits did not result in the precipitation of ␣1 subunits by anti-FLAG-agarose (Fig. 7C) . Anti-␤2 subunit antibodies recognized only two bands with M r 56,000 and 58,000 in forebrain but three to four bands in solubilized preparations of transfected HEK 293 cells. Deglycosylation of native GABA A receptor ␤2 subunits yielded two additional immunoreactive bands (39) . Thus, because the ␤2 subunit is overexpressed in the HEK 293 cells, it is probable that the two additional bands are non-N-glycosylated forms of the ␤2 subunit. It is relevant to compare the intensities of the immunoreactive signals. The solubilized sample (Fig. 7B, 1) is ϳ0.25% of the total ␤2 immunoreactivity applied for the resultant immune pellet (Fig. 7B) , suggesting, in accord with the immunocytochemical observations, a weak or transient interaction between GRIF-1 and the GABA A receptor ␤2 subunit.
Determination of the GRIF-1 and GABA A Receptor ␤2-IL Interacting Domains-The GRIF-1/GABA A receptor ␤2-IL interacting domains were determined by the creation of a series of both GRIF-1-(8 -633) and GABA A receptor ␤2-IL truncation mutants followed by the analysis of protein:protein association using the yeast two-hybrid assay. These studies were all carried out with the GRIF-1 constructs subcloned into the GAL4 AD fish vectors because several N-terminal fragments from aa 1 to 543 of GRIF-1 fused to the GAL4 BD all yielded strong auto-activation of reporter genes without requirement for the GAL4 BD (data not shown). The results are summarized in Figs. 8 and 9 . For the ␤2-IL truncation mutants, it can be deduced that the binding site for GRIF-1 is located between amino acids 324 and 394 (Fig. 8) . Quantitative analysis showed that the relative strength of the interaction between ␤2-IL-(324 -394) and GRIF-1 was 1.4 Ϯ 0.1% (n ϭ 3) of wild-type Gal4p in the yeast strain AH109. This value is similar to that found for the complete ␤2-IL (Table I) . For the GRIF-1 truncation mutants, GRIF-1-(124 -283) was the smallest fragment that still resulted in reporter gene activity following co-expression with the GABA A receptor ␤2-IL-Gal4 BD fusion protein. This 124 -283 region largely coincides with the first coil of the predicted coiled-coil region (Fig. 2) . Interestingly, the Lupas algorithm predicts three coil regions within the ␤2 subunit intracellular loop. One of these, ␤2 348 -361, is completely contained within the region of the ␤2 subunit intracellular loop that retains an interaction with GRIF-1; a second, ␤2 316 -339, is partially within the ␤2 324 -394 interacting domain (Fig. 8) .
DISCUSSION
In this paper, we have characterized a novel 913-amino acid protein, GRIF-1, which was identified by virtue of its specific interaction with the GABA A receptor ␤2-IL in the yeast twohybrid assay system. GRIF-1 mRNA has a wide distribution with major transcripts of 6.2 kb being detected in all tissues analyzed except testis, where a major 2.9-kb transcript was found. GRIF-1 protein, however, is expressed only in excitable tissues, where it was detected in soluble, nuclear, and P2 membrane subcellular fractions of brain, heart, and skeletal muscle by immunoblotting. Overexpression of GRIF-1 or GRIF-1 FLAG in mammalian cells yielded an intracellular localization. Some intracellular co-localization of GRIF-1 and GABA A receptor ␤2 subunits was evident following co-expression of GRIF-1 and ␣1␤2␥2 receptors in mammalian cells. GRIF-1 affinity purification showed in vitro association with ␤2 subunit-containing GABA A receptors in detergent extracts of rat brain. Further, GRIF-1 co-immunoprecipitated GABA A receptor ␤2 subunits, albeit at low efficiency, following co-expression in HEK 293 cells.
Functional Motifs Yielding Insights into the Putative Function of GRIF-1-GRIF-1 and the human orthologue, ALS2CR3, are novel protein sequences. Neither GRIF-1 nor ALS2CR3 have distinguishing amino acid sequence motifs that may have helped to reveal insights into their respective functions. ALS2CR3 was cloned by virtue of its being located in the critical region for juvenile amyotrophic lateral sclerosis on chromosome 2q33-q34. However, no evidence was found to suggest that ALS2CR3 was a causative gene for this form of amyotrophic lateral sclerosis (37) . Secondary structure analyses for both GRIF-1 and the full-length KIAA0549, i.e. ALS2CR3, does predict the presence of two coiled regions within their respective N-terminal regions. These could form a coiled-coil domain that is recognized as being implicated in protein-protein interactions and oligomerization of proteins (reviewed in Ref. 40) . Interestingly, one of the coil regions was found to coincide with a region of GRIF-1 that was homologous to HAP-1A and -1B (Fig. 2) . HAP-1A and -1B are neuronal cytoplasmic proteins that bind to the protein huntingtin and to microtubules. Their subcellular localization is consistent with a role in intracellular transport (36, 41) . Indeed more recently, HAP-1 proteins were found to bind to dynactin p150 Glued (P150), an accessory protein for cytoplasmic dynein that participates in microtubule-dependent retrograde transport of membranous organelles (42) . HAP-1A was also found to associate in a yeast two-hybrid screen with GRIP, a PDZ domaincontaining protein that is thought to be involved in the target- ing of AMPA glutamate receptors (43) . The alignment of all the GRIF-1-related protein sequences revealed the presence of two highly conserved motifs; however, the functional significance of these remains unknown.
Tissue Distribution of GRIF-1-GRIF-1 mRNA, like other GABA A receptor-associated proteins such as gephyrin and GABARAP, has a wide tissue distribution. GRIF-1 protein, however, was expressed only in excitable tissues. This mismatch between mRNA and protein distribution may be a result of the long cDNA probe used for the Northern blot. It is possible that the GRIF-1-(8 -633) cDNA probe also hybridized to mRNA transcripts of the rat homologue of KIAA1042. In brain, heart, and skeletal muscle, GRIF-1 immunoreactivity was found in all subcellular fractions. Overexpression of GRIF-1a in HEK 293 cells yielded an intracellular, non-nuclear distribution. The method used for the subcellular fractionation studies does not generate pure organelles; thus, the ubiquitous presence of GRIF-1 is probably a result of the fact that it is a soluble protein. Interestingly, an M r 88,000 immunoreactive band was found in the nuclear fraction of both smooth and skeletal muscle. This molecular size corresponds to that predicted for the C-terminal truncated variant, GRIF-1b. GRIF-1 does contain a weak leucine zipper motif.
Heterogeneity of GRIF-1-Two alternative splice forms of GRIF-1 were discovered, GRIF-1a and GRIF-1b. The short variant, GRIF-1b, was found to have a deletion that corresponded to exon 15 of the ALS2CR3 gene (37) . There is only a weak splice acceptor site at the intron/exon boundary for exon 15; thus, it may be readily skipped to yield GRIF-1b. GRIF-1b has 672 amino acids and thus a predicted molecular mass of ϳ70 -80 kDa. As described above, a 88-kDa species was recognized by anti-GRIF-1-(8 -633) antibodies in P1 from muscle. In some immunoblots of adult brain, this 88-kDa species was sometimes detected but it was always less abundant than the 115-and 106-kDa species; thus, GRIF-1a is the most prevalent of the expressed splice variants in brain. Heterogeneity of GRIF-1 mRNA because of possible alternative polyadenylation sites in the 3Ј-untranslated region was also apparent in the Northern blot and RACE experiments. Again, analysis of the human KIAA0549/ALS2CR3 gene revealed several strong polyadenylation sites within exon 16 that could give rise to transcripts differing by ϳ2 kb in size. In the Northern blot, the smaller less abundant 4.4-kb transcript is clearly visible, but, because GRIF-1 mRNA has qualitatively the highest expression level in spleen, this may just be a reflection of the overall abundance of GRIF-1 expression. nal isolated interacting clone, was specific to the ␤2-IL of the GABA A receptor subunits tested (Table I ). The GRIF-1-(8 -633) binding domain was localized to a region of 70 amino acids toward the N-terminal end of the bait, i.e. the intracellular loop of the ␤2 subunit (Fig. 8) . It is notable that, when the TM3 and TM4 regions or the TM4 domain alone were included as part of the ␤2-IL bait, no reporter gene activity was detected (Table I) . This suggests, not surprisingly, that the presence of the hydrophobic transmembrane domains affects the conformation of the fusion protein and thus its association with putative interacting partners. GRIF-1-(124 -283), which coincides with the first predicted coil domain of GRIF-1, was the smallest fragment that still interacted with the ␤2-IL-GAL4 BD fusion protein.
Full-length GRIF-1 and the N-terminal domain of the human orthologue, KIAA0549, which includes the 124 -283 ␤2-IL binding site, both associated with the ␤2-IL (Table I) . Quantification of the strength of GRIF-1/␤2-IL binding showed that the interaction was weak, being ϳ1-2% of positive control samples. This may reflect either a low affinity of association or a transient interaction. Alternatively, we have recently shown that, in the yeast two-hybrid screen, GRIF-1-(8 -633) associates with high affinity with itself. 2 Thus, within the co-transformed yeast, there may be competitive interaction between GRIF-1-(8 -633)/GRIF-1-(8 -633) and GRIF-1-(8 -633)/␤2-IL.
Association of GRIF-1 with GABA A Receptors -The association between GABA A receptor ␤2 subunits and GRIF-1 was demonstrated by two different experimental paradigms. In vitro protein interaction assays demonstrated that GRIF-1-(8 -633) specifically associated with ␤2 and ␣1 GABA A receptor subunits in detergent extracts of rat brain, implying that GRIF-1 can associate with assembled GABA A receptors. Coimmunoprecipitation of GRIF-1 and GABA A receptor ␤2 subunits from HEK 293 cells transfected with the respective clones showed that the two proteins do indeed co-associate. For the in vitro protein interaction assays, interestingly, the percentage of ␤2 subunit immunoreactivity specifically precipitated by poly(His)-GRIF-1-(8 -633)-Ni 2ϩ -agarose was always higher than that found for the ␣1 subunit. This may be explained by the co-association of ␤2 with other ␣ subunits in the brain detergent extracts. Alternatively, Tehrani et al. (44) reported that, in clathrin-coated vesicles, GABA A receptors appear to be uncoupled with respect to the GABA modulation of [ 3 H]flunitrazepam binding activity. This is accompanied by a reduction of the ␣1/␤2 subunit ratio in clathrin-coated vesicles compared with synaptic membranes. It was suggested that a selective decline of the ␣1 subunits could account for the uncoupling (44) . The higher percentage of ␤2 compared with ␣1 subunits precipitated by poly(His)-GRIF-1-(8 -633)-Ni 2ϩ -agarose may be explained by an association with unassembled ␤2 subunits as found in clathrin-coated vesicles; thus, GRIF-1 may play a role in the intracellular trafficking or sequestration of ␤2 subunits.
Although GRIF-1 and ␤2 subunits were co-immunoprecipitated from transfected cells, it is important to note that the association between the two proteins was not stoichiometric. This again suggests a low affinity or a transient association in agreement with the quantitative yeast two-hybrid assays, the in vitro protein interaction studies, and the HEK 293 co-localization studies.
Co-immunoprecipitations have also been attempted using native tissue as the source of GRIF-1 and GABA A receptor ␤2 subunits. These experiments have been unsuccessful so far, a major technical difficulty being the presence of the IgG heavy chain in immunoprecipitates. IgG heavy chains have a similar molecular weight to the ␤2 subunit; thus, detection of the latter is masked.
Conclusions-Neurotransmitter receptors are targeted predominantly to the post-synaptic membrane. Although it is recognized that the transport of these proteins to these sites is mediated via molecular motors, it is not yet known how this sorting process occurs. Recently, Setou et al. (45) reported that the neuron-specific microtubule-associated protein, KIF17, forms a complex with mLin-10 to transport vesicles containing the NR2B-containing NMDA receptors to excitatory post-synaptic membranes. It is thus speculated from the homology found to known proteins that the neuronal protein, GRIF-1, which may fulfill a similar function in the transport of ␤2 subunit-containing GABA A receptors to inhibitory post-synaptic membranes, may be a novel GABA A receptor trafficking factor.
